GSP Crop Science Ltd Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Published 3 Aug 2026 | Fertilizers & Agrochemicals | Market Cap: ₹2.8K Cr
GSP Crop Science targets a 5%-7% higher growth rate in revenue over the next 3 years, building on past performance. GSP Crop Science targets a revenue growth rate of 5%-7% annually for the next 3 years, building upon the growth experienced in the last 3 years (Page 10).
From GSP Crop Science Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Price
₹594
Market Cap
₹2.8K Cr
P/E Ratio
26.5
Revenue Rank
Margin Rank
How does GSP Crop Science Ltd rank in Fertilizers & Agrochemicals?
Compare GSP Crop Science Ltd against every Fertilizers & Agrochemicals company this quarter on revenue, margins and earnings-call signals.
GSP Crop Science Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹402 Cr, net profit ₹20 Cr.
Full financials →📊 Revenue & Sales Performance
Rank 3- →GSP Crop Science targets a 5%-7% higher growth rate in revenue over the next 3 years, building on past performance.
- →They expect 40%-50% of revenue in the next 3 years to come from patented products, up from 20% in FY26.
- →The company plans to commercialize 1-2 patented product launches annually to scale these high-margin products.
- →At peak utilization of technical and formulation plants, they project total revenue near INR 1,900-2,000 crores.
- →The plant capacity and potential for de-bottlenecking can support growth for at least 3 years.
- →There is also a strategic focus on expanding patented product registrations and sales internationally, for example in Brazil.
📈 Profitability & Margins
Rank 3- →GSP Crop Science targets a revenue growth rate of 5%-7% annually for the next 3 years, building upon the growth experienced in the last 3 years (Page 10).
- →Patented products, which currently contribute around 20% of revenue, are expected to grow to 40%-50% revenue contribution over the next 3 years, supporting higher margins (Page 9).
- →Patented products carry a 20%-25% higher margin profile compared to generic products, with gross profit margins around 55%-60% versus 35%-40% for generics (Page 9).
- →EBITDA for the 9 months ended December 2025 was INR 153 crore, a 32% increase over last year, indicating operational improvement (Page 5).
- →Management plans cautious product launches, focusing on quality and scalability, with one to two new patented products launched annually (Page 11).
- →Overall, sustained growth driven by patented innovations, higher-margin products, and an expanding domestic and export market footprint is expected.
🏗️ Capital Expenditure Plans
Yes💰 Fundraising & Capital Structure
No information📋 Order Book & Pipeline
No informationKey Metrics
Revenue
Margin
Capex
Fundraise
Order Book
Frequently Asked Questions
What were GSP Crop Science Ltd Q4 FY26 results?
GSP Crop Science targets a 5%-7% higher growth rate in revenue over the next 3 years, building on past performance. GSP Crop Science targets a revenue growth rate of 5%-7% annually for the next 3 years, building upon the growth experienced in the last 3 years (Page 10).
What is GSP Crop Science Ltd share price analysis?
GSP Crop Science Ltd currently shows a below-average growth signal. The stock trades at a P/E of 26.5 with a market cap of ₹2,774 Cr. Investors should review the full earnings analysis for detailed insights.
Is GSP Crop Science Ltd planning capital expenditure?
No information is provided regarding the same in the latest conference call.
Keep GSP Crop Science Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.